# Clinical Trial of Rifampin and Azithromycin for the Treatment of River Blindness

> **NCT00127504** · PHASE2 · COMPLETED · sponsor: **Centers for Disease Control and Prevention** · enrollment: 80 (—)

## Conditions studied

- Onchocerciasis

## Interventions

- **DRUG:** Rifampin
- **DRUG:** Azithromycin

## Key facts

- **NCT ID:** NCT00127504
- **Lead sponsor:** Centers for Disease Control and Prevention
- **Sponsor class:** FED
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-07
- **Primary completion:** —
- **Final completion:** 2004-05
- **Target enrollment:** 80 (—)
- **Last updated:** 2024-08-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00127504

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00127504, "Clinical Trial of Rifampin and Azithromycin for the Treatment of River Blindness". Retrieved via AI Analytics 2026-08-24 from https://api.ai-analytics.org/clinical/NCT00127504. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*